Libero Pharma Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $1.06M

  • Investors
  • 2

Libero Pharma General Information

Description

Developer of a transdermal naltrexone patch designed to deliver naltrexone transdermally instead of a tablet or intramuscular injections. The company's transdermal patch mitigates the issue associated with existing formulations for use in the management of opiate addiction and alcohol use disorder and offers an alternative way of taking naltrexone, enabling doctors to treat patients with the disorder without any common naltrexone side effects.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • International House
  • 38 Thistle Street
  • Edinburgh EH2 1EN
  • Scotland, United Kingdom
+44 01835
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Pharmaceuticals
Vertical(s)
Corporate Office
  • International House
  • 38 Thistle Street
  • Edinburgh EH2 1EN
  • Scotland, United Kingdom
+44 01835

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Libero Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 01-Jan-2022 $1.06M Completed Startup
2. Early Stage VC 10-May-2021 Completed Startup
1. Early Stage VC 29-Apr-2019 $716K $716K Completed Startup
To view Libero Pharma’s complete valuation and funding history, request access »

Libero Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary 7,059 $0.000133 $45.24 $45.24 1x $45.24 2.61%
Ordinary 134,804 $0.000133 $5.43 $5.43 1x $5.43 49.8%
To view Libero Pharma’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Libero Pharma Patents

Libero Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10729686-B2 Pharmaceutical compositions Active 28-Feb-2008
US-20170281562-A1 Pharmaceutical compositions Active 28-Feb-2008
US-20110064788-A1 Pharmaceutical compositions for treatment of addiction Active 28-Feb-2008
US-9700552-B2 Pharmaceutical compositions for treatment of addiction Active 28-Feb-2008 A61K31/485

Libero Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Libero Pharma Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
TRICAPITAL Angel Investors Angel Group Minority
Highland Venture Capital Angel Group Minority
To view Libero Pharma’s complete investors history, request access »

Libero Pharma FAQs

  • When was Libero Pharma founded?

    Libero Pharma was founded in 2018.

  • Where is Libero Pharma headquartered?

    Libero Pharma is headquartered in Edinburgh, United Kingdom.

  • What is the size of Libero Pharma?

    Libero Pharma has 5 total employees.

  • What industry is Libero Pharma in?

    Libero Pharma’s primary industry is Drug Discovery.

  • Is Libero Pharma a private or public company?

    Libero Pharma is a Private company.

  • What is the current valuation of Libero Pharma?

    The current valuation of Libero Pharma is .

  • What is Libero Pharma’s current revenue?

    The current revenue for Libero Pharma is .

  • How much funding has Libero Pharma raised over time?

    Libero Pharma has raised $3.08M.

  • Who are Libero Pharma’s investors?

    TRICAPITAL Angel Investors and Highland Venture Capital have invested in Libero Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process